Results

Total Results: 3,085 records

Showing results for "drug".

  1. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Weinberg.pdf
    March 01, 2004 - All Reporter protections 6 Designated review bodies and sanctioning authority 5 Computerized drug
  2. www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicaid-Inpatient-Weighted.pdf
    September 26, 2023 - 0.00 7,313,787 84.27 86: Neuropsychiatry 4,482 0.05 7,318,269 84.33 87: All other suppliers (e.g., drug
  3. www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/nursing-home/nursinghome-resourcelist.pdf
    April 01, 2023 - psnet.ahrq.gov/primers/primer/23 A growing evidence base supports specific strategies to prevent adverse drug
  4. www.ahrq.gov/patient-safety/settings/hospital/fall-prevention/toolkit/practices.html
    January 01, 2013 - Or, if attendance on rounds is not possible, pharmacists can place recommendations to change drug therapy
  5. www.ahrq.gov/sites/default/files/2025-03/chaudhry-report.pdf
    January 01, 2025 - Final Progress Report: Yale Center for Healthcare Innovation, Redesign, and Learning (CHIRAL) Final Progress Report Project Title: Yale Center for Healthcare Innovation, Redesign, and Learning (CHIRAL) PI: Sarwat I. Chaudhry Yale University Inclusive Dates: 9/30/2014-9/29/2019 Agency for Healthcare Research and Qua…
  6. www.ahrq.gov/healthsystemsresearch/hspc-research-study/research-gaps.html
    June 01, 2020 - 6. Research Gaps and Prioritization of Federally Funded HSR and PCR Health Services and Primary Care Research Study: Comprehensive Report One of the study’s key research questions focuses on identifying research gaps—understudied or underfunded areas in HSR and PCR that, if addressed, would move the fields fo…
  7. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb.pdf
    December 10, 2013 - Transitioning Newborns from NICU to Home: Family Information Packet, Appendix B Appendix B: Clinical Materials to Share With Primary Care Providers Diagnoses and Conditions ■ Anemia of Prematurity ■ Apnea of Prematurity ■ Bronchopulmonary Dysplasia ■ Gastroesophageal Reflux ■ Nephrocalcinosis ■ Patent D…
  8. www.ahrq.gov/sites/default/files/publications2/files/building-state-cooperatives-meeting-summary.pdf
    September 26, 2024 - Building State Cooperatives for Healthcare Improvement: Meeting Summary Contents Contents ..........................................................…
  9. www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2022-Compendium-TechDoc.pdf
    January 01, 2022 - In addition, IQVIA uses Drug Distribution Data that enable quick identification of new organizations … ’s National Plan and Provider Enumeration System (NPPES), State Controlled Substance Registration, Drug
  10. www.ahrq.gov/sites/default/files/publications/files/toolkit.pdf
    September 01, 2005 - • Call center—regional poison center, drug line for national companies, nurse advice line, translation
  11. www.ahrq.gov/sites/default/files/publications/files/implementation-guide_0.pdf
    September 01, 2015 - asymptomatic bacteriuria can lead to antimicrobial resistance, Clostridium difficile infection, and adverse drug
  12. www.ahrq.gov/sites/default/files/publications/files/resphys-champions_2.pdf
    September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile infection, and adverse drug
  13. www.ahrq.gov/sites/default/files/publications/files/resphys-champions.pdf
    September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile infection, and adverse drug
  14. www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/quickref/tobaqrg.pdf
    April 01, 2009 - , MPH, CHES, National Heart, Lung, and Blood Institute Stephen Heishman, PhD, National Institute on Drug
  15. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/impl-guide/implementation-guide.pdf
    September 01, 2015 - asymptomatic bacteriuria can lead to antimicrobial resistance, Clostridium difficile infection, and adverse drug
  16. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/guides/resphys-champions.pdf
    September 01, 2015 - use, thus resulting in more antimicrobial resistance, Clostridium difficile infection, and adverse drug
  17. Value Set Export (xls file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085episiotomycoding.xls
    January 01, 2012 - FFS PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
  18. Value Set Export (xls file)

    www.ahrq.gov/sites/default/files/wysiwyg/CHIPRA-BMI-Coding.xls
    January 01, 2012 - FFS PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
  19. www.ahrq.gov/sites/default/files/2024-12/dalton-report.pdf
    January 01, 2024 - Under these conditions, safe treatment options include expectant management and drug therapy to cause
  20. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/playbook.pdf
    April 01, 2022 - A Playbook for Preventing CLABSI and CAUTI in the ICU Setting AHRQ Safety Program for Intensive Care Units: Preventing CLABSI and CAUTI A Playbook for Preventing CLABSI and CAUTI in the ICU Setting 2 Playbook AHRQ Safety Program for Intensi…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: